Bicycle Therapeutics announces continued clinical progress and updates to management team

Clinical Impact

Jan 5

Written By Frances Benson

https://investors.bicycletherapeutics.com/news-releases/news-release-details/bicycle-therapeutics-announces-continued-clinical-progress-and

2022

Frances Benson

ADARx Pharmaceuticals appoints Dr. Hubert Chen as CMO

Second Genome granted U.S. patent for proteins for the treatment or prevention of epithelial barrier function disorders